NEW ON THE MARKET
First Rho kinase inhibitor for glaucoma: netarsudil (in ROCLANDA)
a-t READERS QUESTIONS AND COMMENTS
Hepatitis B vaccine HEPLISAV B
FAST trial: gout medication febuxostat (ADENURIC, generics) rehabilitated?
Does daily intake of vitamin D reduce cancer mortality?
THERAPY FROM A CRITICAL VIEWPOINT
WHO advises not to use non-sugar sweeteners
BEWARE MISINFORMATION
Misleading advertisement for desvenlafaxine (DESVENEURAX) free article
IN BRIEF
Deutsches Ärzteblatt adheres to advertising column “PHARMA”
Clinical trials – improvement required concerning endpoints and registration
Youth protection: need for action regarding e-cigarettes
e a-t ON THE INTERNET
First Rho kinase inhibitor for glaucoma: netarsudil (in ROCLANDA) (long version)